Cold Plasma Technologies

Cold Plasma Technologies is a medical technology company specializing in the application of cold atmospheric plasma (CAP) for advanced wound care and infection management. The company's core technology generates a non-thermal ionized gas that effectively eradicates a broad spectrum of pathogens, including antibiotic-resistant bacteria, without damaging healthy human tissue. Their primary clinical focus is on treating chronic, non-healing wounds such as diabetic foot ulcers and pressure sores, which represent a significant burden on the healthcare system. By integrating plasma physics with biological science, Cold Plasma Technologies aims to provide a safe, painless, and highly effective treatment modality that accelerates the healing process and reduces the need for systemic antibiotics. The technology is based on extensive research into plasma physics and its interactions with biological systems, positioning the company as a leader in the emerging field of plasma medicine.